2025 Biomarkers Cholesterol 
CardiacWire
JUNE 19, 2024
Marea Therapeutics emerged this week , announcing $190M in Series A/B funding and a mission to develop “a new generation of medicines for cardiometabolic diseases” – starting with their drug candidate targeting remnant cholesterol. Marea got its start from a tweet by UCSF cardiologist Ethan J.
Dr. Malcolm Kendrick
OCTOBER 30, 2024
I, Dr Malcolm Kendrick, with or without other co-conspirators, would be accused of spreading misinformation about cholesterol and statins. The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. With thousands dying.
Expert insights. Personalized for you.
59 
Let's personalize your content